Lifeward Ltd. (LFWD) shareholders
Close on Nov 17, 2026Market cap $8.78MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 1,528,221 | 49.90% | 13D (active) | Mar 25, 2026 |
| Lind Global Fund II LP Joint filing with Lind Global Partners II LLC (8.90%), Easton Jeff (8.90%) | 945,746 | 8.90% | 13G (passive) | Jan 6, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of LFWD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 18,064 | 0.64% | $141.80K | New | 0.00% |
| Renaissance Technologies LLC | 11,327 | 0.40% | $86.77K | −100 | 0.00% |
| UBS Group AG | 2,152 | 0.08% | $16.48K | +27 | 0.00% |
| Morgan Stanley | 274 | 0.01% | $2.10K | +66 | 0.00% |
| SBI Securities Co., Ltd. | 196 | 0.01% | $1.50K | – | 0.00% |
| Osaic Holdings, Inc. | 107 | 0.00% | $836 | – | 0.00% |
| Royal Bank of Canada | 50 | 0.00% | $0 | New | 0.00% |
| National Bank Of Canada /Fi/ | 11 | 0.00% | $85 | – | 0.00% |
| Caitong International Asset Management Co., Ltd | 4 | 0.00% | $31 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 9 | 0M | 1.1% | 2 / 2 | 1 / 1 | 0M | 0M |
| Q1 2026 | 8 | 0M | 0.5% | 8 / 0 | 0 / 0 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Mark Grant | President & CEO, Director | – | – | Mar 27, 2026 |
| Lawrence J. Jasinski | Chief Executive Officer, Director | 100,870 | 3.56% | May 22, 2025 |
| Ronen Tsimerman | Chief Financial Officer | – | – | Nov 3, 2026 |
| Keith Dale Rose | Chief Medical Officer | 17,083 | 0.60% | May 20, 2026 |
| Almog Adar | Chief Financial Officer | 262,500 | 9.27% | Mar 27, 2026 |
| Jeannine Lynch | VP of Market Access & Strategy | 142,134 | 5.02% | Dec 12, 2025 |
| Ariel Kallner | Director | – | – | Nov 12, 2026 |
| Haggai Zamir | Director | 6,711 | 0.24% | Sep 10, 2026 |
| Yonason Greenwald | Director | 6,711 | 0.24% | Aug 28, 2026 |
| Avraham Gabay | Director | 13,643 | 0.48% | Aug 24, 2026 |
| Moshe H. Rozenbaum | Director | 11,485 | 0.41% | Apr 13, 2026 |
| William Mark Sigsbee | Director | 11,485 | 0.41% | Apr 13, 2026 |
| Yehuda Reznick | Director | 7,657 | 0.27% | Mar 27, 2026 |
| Nadav Kidron | Director | 7,657 | 0.27% | Mar 27, 2026 |
| Miriam Kidron | Director | 7,657 | 0.27% | Mar 27, 2026 |
| John William Poduska Sr | Director | 55,953 | 1.98% | Aug 7, 2025 |
| Randel Richner | Director | 57,487 | 2.03% | Aug 7, 2025 |
| Robert J. Marshall Jr. | Director | 35,920 | 1.27% | Aug 7, 2025 |
| Joseph E. Turk Jr | Director | 104,973 | 3.71% | Aug 7, 2025 |
| Hadar Levy | Director | 51,576 | 1.82% | Aug 7, 2025 |
| Michael Swinford | Director | 100,960 | 3.56% | Aug 7, 2025 |
| Joshua Hexter | – | – | – | Sep 1, 2026 |
| Pharmaceuticals Inc. Oramed | 10% owner | 1,250,363 | 44.15% | May 14, 2026 |
| Global Fund II LP Lind | 10% owner | 10,875,741 | 384.03% | Jan 8, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Avraham Gabay Director | Aug 20, 2026 | Award | +13,643 | – | – | 13,643 |
| Haggai Zamir Director | Aug 14, 2026 | Award | +6,711 | – | – | 6,711 |
| Yonason Greenwald Director | Aug 14, 2026 | Award | +6,711 | – | – | 6,711 |
| Keith Dale Rose Chief Medical Officer | May 1, 2026 | Award | +15,000 | – | – | 17,083 |
| Moshe H. Rozenbaum Director | Mar 25, 2026 | Award | +11,485 | – | – | 11,485 |
| William Mark Sigsbee Director | Mar 25, 2026 | Award | +11,485 | – | – | 11,485 |
| Miriam Kidron Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Yehuda Reznick Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Nadav Kidron Director | Mar 25, 2026 | Award | +7,657 | – | – | 7,657 |
| Jeannine Lynch VP of Market Access & Strategy | Dec 11, 2025 | Award | +50,000 | – | – | 96,067 |
| Jeannine Lynch VP of Market Access & Strategy | Sep 2, 2025 | Sale | −1,591 | $0.64 | $1.02K | 46,067 |
| Joseph E. Turk Jr Director | Aug 1, 2025 | Award | +71,839 | – | – | 86,457 |
| Robert J. Marshall Jr. Director | Aug 1, 2025 | Award | +35,920 | – | – | 35,920 |
| John William Poduska Sr Director | Aug 1, 2025 | Award | +35,920 | – | – | 55,953 |
| Michael Swinford Director | Aug 1, 2025 | Award | +35,920 | – | – | 45,960 |
| Hadar Levy Director | Aug 1, 2025 | Award | +35,920 | – | – | 51,576 |
| Randel Richner Director | Aug 1, 2025 | Award | +35,920 | – | – | 57,487 |
| Lawrence J. Jasinski Chief Executive Officer, Director | May 21, 2025 | Sale | −1,909 | $1.26 | $2.41K | 98,728 |
| Global Fund II LP Lind 10% owner | Jan 7, 2025 | Sale | −700 | $2.69 | $1.88K | 857,996 |
| Global Fund II LP Lind 10% owner | Jan 7, 2025 | Sale | −190,734 | $1.94 | $370.02K | 858,696 |
| Global Fund II LP Lind 10% owner | Jan 6, 2025 | Sale | −298,350 | $3.46 | $1.03M | 1,049,430 |
| Global Fund II LP Lind 10% owner | Jan 6, 2025 | Sale | −83,326 | $3.01 | $250.81K | 1,347,780 |
| Randel Richner Director | Dec 13, 2024 | Sale | −4,285 | $1.68 | $7.20K | 0 |
| Joseph E. Turk Jr Director | Dec 13, 2024 | Buy | +6,000 | $1.69 | $10.14K | 18,516 |
| Michael Swinford Director | Nov 25, 2024 | Buy | +21,622 | $2.03 | $43.89K | 65,040 |
| Michael Swinford Director | Nov 22, 2024 | Buy | +16,907 | $1.83 | $30.94K | 43,418 |
| Michael Swinford Director | Nov 20, 2024 | Buy | +16,471 | $1.84 | $30.31K | 26,511 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Sep 13, 2024 | Sale | −2,672 | $3.26 | $8.71K | 100,637 |
| Jeannine Lynch VP of Market Access & Strategy | Sep 3, 2024 | Sale(10b5-1 plan) | −1,625 | $3.30 | $5.36K | 47,658 |
| Jeannine Lynch VP of Market Access & Strategy | Aug 2, 2024 | Sale(10b5-1 plan) | −1,783 | $3.84 | $6.85K | 49,283 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Aug 2, 2024 | Sale | −2,665 | $3.84 | $10.23K | 103,309 |
| Jeannine Lynch VP of Market Access & Strategy | Jul 1, 2024 | Sale(10b5-1 plan) | −1,834 | $3.83 | $7.02K | 51,066 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Jun 18, 2024 | Sale | −3,466 | $4.22 | $14.63K | 105,974 |
| Michael A. Lawless Chief Financial Officer | May 23, 2024 | Buy | +2,000 | $4.97 | $9.94K | 4,150 |
| Joseph E. Turk Jr Director | May 23, 2024 | Buy | +7,916 | $5.01 | $39.66K | 12,516 |
| Joseph E. Turk Jr Director | May 22, 2024 | Buy | +84 | $5.01 | $421 | 4,600 |
| Lawrence J. Jasinski Chief Executive Officer, Director | May 21, 2024 | Sale | −1,620 | $4.91 | $7.95K | 109,440 |
| Michael Swinford Director | Apr 18, 2024 | Award | +10,040 | – | – | 10,040 |
| Global Fund II LP Lind 10% owner | Nov 20, 2023 | Buy | +12,000 | $0.73 | $8.76K | 10,017,745 |
| Global Fund II LP Lind 10% owner | Nov 17, 2023 | Buy | +42,917 | $0.73 | $31.33K | 10,005,745 |
| Global Fund II LP Lind 10% owner | Nov 14, 2023 | Buy | +72,818 | $0.68 | $49.52K | 9,962,828 |
| Global Fund II LP Lind 10% owner | Sep 26, 2023 | Sale(10b5-1 plan) | −5,031,200 | $0.70 | $3.52M | 0 |
| Global Fund II LP Lind 10% owner | Sep 26, 2023 | Buy | +5,031,200 | $0.70 | $3.52M | 9,890,010 |
| John William Poduska Sr Director | Sep 13, 2023 | Award | +59,595 | – | – | 140,240 |
| Randel Richner Director | Sep 13, 2023 | Award | +59,595 | – | – | 150,980 |
| Jeff Dykan Director | Sep 13, 2023 | Award | +59,595 | – | – | 119,157 |
| Hadar Levy Director | Sep 13, 2023 | Award | +59,595 | – | – | 109,595 |
| Lawrence J. Jasinski Chief Executive Officer, Director | Sep 13, 2023 | Award | +200,000 | – | – | 751,276 |
| Joseph E. Turk Jr Director | Sep 13, 2023 | Award | +59,595 | – | – | 102,330 |
| Joseph E. Turk Jr Director | Sep 7, 2023 | Buy | +27,309 | $0.68 | $18.57K | 31,616 |
| Joseph E. Turk Jr Director | Sep 6, 2023 | Buy | +30 | $0.68 | $20 | 4,307 |
| Global Fund II LP Lind 10% owner | Sep 6, 2023 | Buy | +161 | $0.69 | $111 | 4,858,810 |
| Global Fund II LP Lind 10% owner | Sep 5, 2023 | Buy | +19,779 | $0.70 | $13.85K | 4,858,649 |
| Global Fund II LP Lind 10% owner | Sep 1, 2023 | Buy | +11,597 | $0.71 | $8.23K | 4,838,870 |
| Joseph E. Turk Jr Director | Sep 1, 2023 | Buy | +2,661 | $0.68 | $1.81K | 4,277 |
| Jeannine Lynch VP of Market Access & Strategy | Aug 31, 2023 | Sale(10b5-1 plan) | −9,529 | $0.69 | $6.58K | 370,303 |
| Joseph E. Turk Jr Director | Aug 29, 2023 | Buy | +1,616 | $0.62 | $1.00K | 1,616 |
| Global Fund II LP Lind 10% owner | Aug 28, 2023 | Buy | +9,125 | $0.64 | $5.84K | 4,827,273 |
| Global Fund II LP Lind 10% owner | Aug 25, 2023 | Buy | +16,020 | $0.62 | $9.93K | 4,818,148 |
| Michael A. Lawless Chief Financial Officer | Aug 25, 2023 | Buy | +5,000 | $0.62 | $3.10K | 15,051 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Lifeward's stock actually held short. Settlement fails (shares not delivered on time) peaked at 1,476 shares on Sep 24, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Lawrence J. Jasinski Officer | Sep 16, 2024 | 2,672 | $8.74K | Sep 13, 2024 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Aug 5, 2024 | 2,665 | $11.78K | Aug 2, 2024 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Jun 20, 2024 | 3,466 | $15.15K | Jun 18, 2024 | Restricted Stock Units |
| Ichiki Yasushi Director | Nov 20, 2023 | 15,607 | $11.83K | Nov 17, 2023 | Restricted stock unit |
| Ichiki Yasushi Director | Nov 17, 2023 | 15,038 | $10.98K | Nov 16, 2023 | Restricted stock unit |
| Dan Aryeh Director | Sep 18, 2023 | 2,515 | $2.14K | Sep 15, 2023 | Restricted stock unit |
| Dan Aryeh Director | Aug 23, 2023 | 9,582 | $6.49K | Aug 15, 2023 | RSU |
| Lawrence J. Jasinski Officer | Aug 3, 2023 | 15,237 | $11.05K | Aug 2, 2023 | Restricted Stock Units |
| Lawrence J. Jasinski Officer | Jun 21, 2023 | 22,920 | $13.87K | Jun 20, 2023 | RSU |
See a number that looks wrong?